Delayed vaccines and variants risk spike in Africa; Portugal, Iceland, Malta expected to be on UK green list; India cases rise by world record 414,188
- New concerns as Indian Covid variant clusters found across England
- EU wants three ‘course-changing’ Covid drugs from October
- Living through India’s pandemic: ‘Oxygen is the new currency’
- Japan to extend Covid emergency in Tokyo as Olympics loom
- Choice of Covid vaccines to be offered to Britons under 40
India’s Biological E. Ltd will soon start Phase III trials of its vaccine, and plans producing up to 80 million doses a month from August.
Reuters reports:
The company has developed the vaccine with Baylor College of Medicine in Houston and Dynavax Technologies Corp. Late last month it received approval from India’s drug regulator to conduct a Phase III clinical trial, which Managing Director Mahima Datla said would begin soon.
Government officials have said the vaccine, which uses the recombinant-protein technology in which a harmless agent is used to stimulate an immune response in cells, could be rolled out in the country from August.
Datla said Biological E. would apply for emergency use authorisation (EUA) for the drug based on government advice.
Unused coronavirus vaccines in Japan are set to reach tens of millions of doses, as the country is poised to approve two more shots in coming weeks and the pace of its inoculation campaign remains slow.
Reuters reports that Japan imported 28 million doses of Pfizer Inc’s COVID-19 vaccine through late April, but has so far used only 15% of the stockpile, with the remaining 24 million doses sitting in freezers.
Continue reading...source https://www.theguardian.com/world/live/2021/may/07/coronavirus-live-news-who-warns-of-risk-of-second-wave-in-africa-india-cases-rise-by-world-record-414188
No comments:
Post a Comment